Vanacker H, Treilleux I, Schiffler C, Bieche I, et al. p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane. Br J Cancer 2024 Jan 5. doi: 10.1038/s41416-023-02549.
PMID: 38182687